Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03836430 · ClinicalTrials.gov registry record · NA

The Impact of a Newborn Behavioral Intervention on the Mental Health of Mothers With Late Pre-Term Infants

A NA study of Postpartum Depression and Infant Development, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
208
Enrollment target
1
Study location

NCT03836430 is a NA study of Postpartum Depression and Infant Development that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 208 participants, below the 529-participant average among 38 other Postpartum Depression trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03836430, a NA study of Postpartum Depression and Infant Development, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
208 participants
Enrollment target
1
Study location

Study Summary

Preterm birth is a serious public health issue, affecting 10% of all births in the US alone. Three quarters of these infants are born between 34 0/7 and 36 6⁄7 weeks' gestation or late-preterm (LP). Mothers of LP infants are at increased risk for postpartum stress, depression and mother-infant interaction problems posing significant risks for infant development. Our proposed project will advance the fields of maternal and child health by examining the impact of the Newborn Behavioral Observations Family Wellness (NBO-FW), a dyadic, two generational intervention targeting maternal wellbeing and early mother-infant relations in families of LP born infants. The NBO-FW is a 12week preventative intervention aimed at promoting maternal mental health and positive parenting. It is based on the highly successful NBO intervention developed by our team and applied across five continents, but with important new elements targeting maternal mental health and the needs of high-risk LP infants and their families. Participants will consist of 200 first-time mothers and their LP infants (100 intervention and 100 control dyads) born at Brigham and Women's Hospital (BWH), an urban teaching hospital of Harvard Medical School and the largest maternity care provider in Boston. Data will be collected at three time points: during the birth hospitalization, at a follow-up visit at 4-6 weeks corrected gestational age, and at a further visit 10-12 weeks after birth. Outcomes will include standardized measures of maternal stress, depression, parenting confidence, and observed mother-infant interaction. Information about infant health care practices and maternal/infant health will also be recorded. We hypothesize that, compared to mothers in the care as usual control group, first-time mothers of LP infants who receive the NBO-FW will demonstrate a) lower levels of stress and depression, b) greater parenting confidence, c) higher quality interactions with their infants (e.g., positive affect, sen

Interventions

  • BEHAVIORAL Newborn Behavioral Observation-Family Wellness (NBO-FW)

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 208 participants
Start Date 2019-08-01
Est. Completion 2022-05-05
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT03836430

The ClinicalTrials.gov registry entry for NCT03836430 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 529-participant average among 38 other Postpartum Depression trials with a reported enrollment target (61% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Postpartum Depression appearing as the primary indexed condition, and to 1 intervention - of which Newborn Behavioral Observation-Family Wellness (NBO-FW) is the first listed.

NCT03836430 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03836430 about?

NCT03836430 is a clinical study titled "The Impact of a Newborn Behavioral Intervention on the Mental Health of Mothers With Late Pre-Term Infants". Preterm birth is a serious public health issue, affecting 10% of all births in the US alone. Three quarters of these infants are born between 34 0/7 and 36 6⁄7 weeks' gestation or late-preterm (LP). Mothers of LP infants are at increased risk for postpartum stress, depression and mother-infant inter...

What is the current status of trial NCT03836430?

This trial is currently completed. It is a NA study. The enrollment target is 208 participants. The study started on 2019-08-01. Estimated completion is 2022-05-05.

What conditions does trial NCT03836430 study?

This clinical trial studies the following conditions: Postpartum Depression, Infant Development, Preterm Infant.

What interventions are being tested in trial NCT03836430?

The interventions under investigation include: Newborn Behavioral Observation-Family Wellness (NBO-FW) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03836430?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03836430 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postpartum Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.